Results 11 to 20 of about 1,302,625 (339)

Psoriasis: To Vaccinate or Not to Vaccinate? [PDF]

Cureus, 2021
Psoriasis is a chronic, inflammatory, autoimmune disease characterized by red, dry, itchy, and scaly patches of abnormal skin growth on the elbows, knees, and/or scalp, which can negatively impact a patient's quality of life and activities of daily living.
Marc M Kesselman, Michelle Demory Beckler, Poonam Patel, Christian Summa   +3 more
openaire   +3 more sources

Acknowledgment to Reviewers of Vaccines in 2021

Vaccines, 2022
Rigorous peer-reviews are the basis of high-quality academic publishing [...]
Vaccines Editorial Office
doaj   +1 more source

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

British medical journal, 2021
Objective To estimate the real world effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S vaccines against confirmed covid-19 symptoms (including the UK variant of concern B.1.1.7), admissions to hospital, and deaths.
J. Lopez Bernal, N. Andrews, C. Gower, C. Robertson, J. Stowe, E. Tessier, R. Simmons, S. Cottrell, R. Roberts, M. O’Doherty, K. Brown, C. Cameron, D. Stockton, J. McMenamin, M. Ramsay   +14 more
semanticscholar   +1 more source

Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability

npj Vaccines, 2023
During the COVID-19 pandemic, Pfizer-BioNTech and Moderna successfully developed nucleoside-modified mRNA lipid nanoparticle (LNP) vaccines. SARS-CoV-2 spike protein expressed by those vaccines are identical in amino acid sequence, but several key ...
Lizhou Zhang, Kunal R. More, Amrita Ojha, C. B. Jackson, Brian D. Quinlan, Hao Li, Wenhui He, M. Farzan, N. Pardi, H. Choe   +9 more
semanticscholar   +1 more source

Cancer vaccines as promising immuno-therapeutics: platforms and current progress

Journal of Hematology & Oncology, 2022
Research on tumor immunotherapy has made tremendous progress in the past decades, with numerous studies entering the clinical evaluation. The cancer vaccine is considered a promising therapeutic strategy in the immunotherapy of solid tumors.
Jian Liu, Minyang Fu, Manni Wang, Dandan Wan, Yuquan Wei, Xiawei Wei   +5 more
semanticscholar   +1 more source

Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.

Asian Pacific Journal of Allergy and Immunology, 2020
As the world is witnessing the epidemic of COVID-19, a disease caused by a novel coronavirus, SARS-CoV-2, emerging genetics and clinical evidences suggest a similar path to those of SARS and MERS.
E. Prompetchara, C. Ketloy, T. Palaga
semanticscholar   +1 more source

Lessons Learned and Future Perspectives for Rotavirus Vaccines Switch in the World Health Organization, Regional Office for Africa

Vaccines, 2023
Background: Following the World Health Organization (WHO) recommendation, 38/47 countries have introduced rotavirus vaccines into the program of immunization in the WHO Regional Office for Africa (WHO/AFRO).
I. Mandomando, Augusto Messa, J. Biey, Gilson Paluku, Mutale Mumba, J. Mwenda   +5 more
semanticscholar   +1 more source

Expression of Concern: Artigas-Jerónimo et al. A Novel Combined Scientific and Artistic Approach for the Advanced Characterization of Interactomes: The Akirin/Subolesin Model. Vaccines 2020, 8, 77

Vaccines, 2020
The Editorial Office of Vaccines has decided to issue the following Expression of Concern about the published paper: A Novel Combined Scientific and Artistic Approach for the Advanced Characterization of Interactomes: The Akirin/Subolesin Model [...]
Vaccines Editorial Office
doaj   +1 more source

A research agenda for malaria eradication: vaccines. [PDF]

PLoS Medicine, 2011
Vaccines could be a crucial component of efforts to eradicate malaria. Current attempts to develop malaria vaccines are primarily focused on Plasmodium falciparum and are directed towards reducing morbidity and mortality.
malERA Consultative Group on Vaccines
doaj   +1 more source

Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries

Human Vaccines & Immunotherapeutics, 2022
Vaccine impact models against rotavirus disease (RD) and pneumococcal disease (PD) in low- and middle-income countries assume vaccine coverage based on other vaccines.
Alen Marijam, Lode Schuerman, Patricia Izurieta, Priya Pereira, Désirée Van Oorschot, Shailesh Mehta, Martin OC Ota, Baudouin Standaert   +7 more
doaj   +1 more source